Brief: Agile Therapeutics Reports Q3 2020 Financial Results

Agile Therapeutics

12/11/2020 21:28

Nov 12 (Reuters) - Agile Therapeutics Inc  AGRX.O :
    * AGILE THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
    * Q3 LOSS PER SHARE $0.18
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.18 -- REFINITIV IBES
DATA
    * AGILE THERAPEUTICS - $71.9 MILLION IN CASH, CASH
EQUIVALENTS,
AND MARKETABLE SECURITIES AS OF SEPTEMBER 30
    * AGILE THERAPEUTICS - COMMERCIAL LAUNCH OF TWIRLA EXPECTED
BY
YEAR-END 2020
    * AGILE THERAPEUTICS - EXPECTS GROSS REVENUE IN Q4,
REFLECTING
EXPECTATIONS OF INITIAL STOCKING OF TWIRLA BY WHOLESALERS, TO BE
ABOUT $1 MILLION
    * AGILE - BELIEVES CASH, CASH EQUIVALENTS, MARKETABLE
SECURITIES
AS OF SEPT. 30 TO BE SUFFICIENT TO MEET PROJECTED OPERATING.
REQUIREMENTS THROUGH 2021-END

Source text for Eikon:  ID:nGNX2YzscD 
Further company coverage:  AGRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))